Bioline Rx reported $-673K in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Arca Biopharma USD -34.43M 326K Dec/2025
Bio Path USD -488K 4.07M Sep/2025
Bioline Rx USD -673K 2.99M Sep/2025
Capricor Therapeutics USD -29.16M 2.87M Dec/2025